JENNIFER POPE: Open Payments
NPI 1720477151 · ROBERTSDALE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$912 in 44 payments from 15 companies in 2025. Trend: 2023 $1,104 · 2024 $1,364 · 2025 $912
Food & beverage: $912
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $192 |
| GlaxoSmithKline, LLC. | 9 | $172 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $145 |
| ABBVIE INC. | 3 | $60 |
| Novo Nordisk Inc | 3 | $55 |
| Lundbeck LLC | 3 | $50 |
| Exact Sciences Corporation | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $33 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
Products named: TRELEGY ELLIPTA, Kerendia, FARXIGA, REXULTI, Ozempic, AIRSUPRA, The Cologuard Plus Collection Kit, VRAYLAR.
Industry payments across AL — which companies pay providers there.
